SEC Form 4 · accession 0001162194-15-000022
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuel D Colella
Director
Period of report
Feb 18, 2015
Accepted (ET)
Feb 20, 2015 · 6:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 18, 2015 | M | 8,800 | $16.00 | A | 28,473 | D | |
| Common StockF2 | Feb 18, 2015 | S | 8,800 | $38.7112 | D | 19,673 | D | |
| Common StockF1 | holding | — | — | — | 5,561 | I | Colella Family Partners, L.P |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $16.00 | Feb 18, 2015 | M | 8,800 | D | — | Jun 6, 2023 | Common Stock | 8,800 | 3,200 | D |
Explanation of responses
- F1The shares are held by Colella Family Partners, L.P. ("Colella Partners"). The Reporting Person is the General Partner of Colella Partners. The Reporting Person disclaims beneficial ownership of such shares held by Colella Partners, except to the extent of his proportionate pecuniary interest therein, if any.
- F2The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.50 to $38.86, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F3The shares subject to the Option fully vested on June 6, 2014.